Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
283M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
215M
-
Shares change
-
-3.19M
-
Total reported value, excl. options
-
$469M
-
Value change
-
-$3.52M
-
Put/Call ratio
-
0.11
-
Number of buys
-
53
-
Number of sells
-
-60
-
Price
-
$2.18
Significant Holders of Erasca, Inc. - Common Stock (ERAS) as of Q3 2025
158 filings reported holding ERAS - Erasca, Inc. - Common Stock as of Q3 2025.
Erasca, Inc. - Common Stock (ERAS) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 215M shares
of 283M outstanding shares and own 75.87% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (22.7M shares), T. Rowe Price Investment Management, Inc. (20.2M shares), VR ADVISER, LLC (17.9M shares), Logos Global Management LP (15.2M shares), BlackRock, Inc. (15.1M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (14.5M shares), Paradigm Biocapital Advisors LP (13.6M shares), VANGUARD GROUP INC (12.8M shares), ARCH Venture Management, LLC (11.1M shares), and Vivo Capital, LLC (9.27M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.